Showing results (1-10 of 456) with videos related to
Sort By:
Pageof 46
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 14, 2016
Rare coagulation disorders: fibrinogen, factor VII and factor XIIIP de Moerloose, J-F Schved, D NugentAnnales Francaises D'Anesthesie Et De Reanimation|February 21, 2013
[Rare bleeding disorders and invasive procedures]F Bonhomme, J-F Schved, M Giansily-Blaizot, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|August 8, 2013
Cancer detection and management in patients with haemophilia: a retrospective European multicentre studyC Biron-Andreani, P de Moerloose, R D'oiron, et al.La Revue De Medecine Interne|July 15, 2009
[The concept of aspirin "resistance": mechanisms and clinical relevance]J-L Reny, R F Bonvini, I Barazer, et al.The Annals of Thoracic Surgery|December 1, 1996
Laboratory evaluation of hemostasis before cardiac operationsP de MoerlooseTransfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|December 6, 2005
Preoperative autologous blood donation: a therapy that needs to be scientifically evaluatedJ-F SchvedAnnales Francaises D'Anesthesie Et De Reanimation|May 26, 2004
[Do we need autologous blood donation?]J-F SchvedTransfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine|May 3, 2015
[Hemorrhagic congenital diseases: What can be the future of plasma-derived products against recombinants?]J-F SchvedJournal of Thrombosis and Haemostasis : JTH|September 24, 2010
Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE studyP Fontana, P Berdagué, C Castelli, et al.Revue Medicale De La Suisse Romande|June 13, 2001
[Thrombopenias induced by heparin: diagnostic and therapeutic innovations]M Righini, P de MoerloosePageof 46